FDA Approves Darzalex Combo Therapy for Previously Treated Multiple Myeloma Patients
The U.S. Federal Drug Administration has approved a combination of the immunotherapies Darzalex (daratumumab), Pomalyst (pomalidomide) and dexamethasone as a multiple myeloma treatment, according to…